Oct 3 |
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
|
Oct 1 |
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Sep 30 |
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
|
Sep 27 |
Wave put on J.P. Morgan Positive Catalyst Watch ahead of data readout
|
Sep 26 |
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
|
Sep 26 |
Wave Life Sciences prices $200M stock offering
|
Sep 26 |
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
|
Sep 25 |
General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday
|
Sep 25 |
WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study
|
Sep 25 |
Wave’s stock swells as it eyes approval following Phase II DMD victory
|